Viemed Healthcare (VMD) Stock Price, News & Analysis

Company Overview

Viemed Healthcare, Inc. (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States. The company partners with hospitals, skilled nursing facilities, and physician practices to facilitate smooth transitions from acute care to the home setting. Viemed’s model emphasizes early intervention, patient education, and close monitoring to reduce hospital readmissions and improve quality of life for individuals with chronic respiratory conditions such as COPD, neuromuscular diseases, and spinal cord injuries.

In addition to equipment delivery, Viemed provides telemonitoring and home health services, enabling continuous remote oversight of patient ventilation parameters and clinical status. Its clinical team works collaboratively with referring physicians to adjust care plans in real time and to address emerging respiratory needs. Through these integrated services, Viemed aims to enhance patient outcomes, lower overall healthcare costs, and set a standard for home respiratory care across its service regions.

Key Stats

• Today's Range: $9.44 to $9.66
• 50-Day Range: $8.52 to $10.05
• 52-Week Range: $5.93 to $10.18
• Volume: 34,009 shs
• Average Volume: 252,471 shs
• Market Capitalization: $369.19 million
• P/E Ratio: 26.01
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Hold

Viemed Healthcare Stock Analysis - MarketRank™

Viemed Healthcare scored higher than 31% of companies evaluated by MarketBeat, and ranked 732nd out of 856 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.0 / 5
• Analyst Rating: Hold

Consensus Rating

Viemed Healthcare has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 2 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Viemed Healthcare has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 31.82%

Earnings Growth

Earnings for Viemed Healthcare are expected to grow by 31.82% in the coming year, from $0.44 to $0.58 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Viemed Healthcare is 26.20, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.52.

Price to Earnings Ratio vs. Sector

The P/E ratio of Viemed Healthcare is 26.20, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 20.82.

Price to Book Value per Share Ratio

Viemed Healthcare has a P/B Ratio of 2.50. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.46% of the float of Viemed Healthcare has been sold short.

Short Interest Ratio / Days to Cover

Viemed Healthcare has a short interest ratio ("days to cover") of 2.04, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Viemed Healthcare has recently increased by 27.19%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Viemed Healthcare does not currently pay a dividend.

Dividend Growth

Viemed Healthcare does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

MarketBeat Follows

5 people have added Viemed Healthcare to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 2.1 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Viemed Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,237,976.00 in company stock.

Percentage Held by Insiders

20.00% of the stock of Viemed Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

74.24% of the stock of Viemed Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 5/05/2026
• Today: 5/21/2026
• Next Earnings (Estimated): 8/05/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:VMD
• CIK: 1729149
• Web: www.viemed.com
• Phone: (337) 504-3802
• Fax: N/A
• Employees: 1,382
• Year Founded: 2006

Profitability

• EPS (Trailing Twelve Months): $0.37
• Trailing P/E Ratio: 26.08
• Forward P/E Ratio: 21.90
• P/E Growth: N/A
• Net Income: $14.93 million
• Net Margins: 5.20%
• Pretax Margin: 7.71%
• Return on Equity: 10.52%
• Return on Assets: 7.60%

Debt

• Debt-to-Equity Ratio: 0.06
• Current Ratio: 1.22
• Quick Ratio: 1.10

Sales & Book Value

• Annual Sales: $286.57 million
• Price / Sales: 1.29
• Cash Flow: $1.15 per share
• Price / Cash Flow: 8.35
• Book Value: $3.80 per share
• Price / Book: 2.54

Miscellaneous

• Outstanding Shares: 38,337,000
• Free Float: 30,670,000
• Market Cap: $369.38 million
• Optionable: Not Optionable
• Beta: 1.15